These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24488436)

  • 1. The coexistence of second and third malignancies in adult-onset cancer patients.
    Giuliani J
    J Gastrointest Cancer; 2014 Sep; 45(3):395. PubMed ID: 24488436
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood.
    Tukenova M; Guibout C; Hawkins M; Quiniou E; Mousannif A; Pacquement H; Winter D; Bridier A; Lefkopoulos D; Oberlin O; Diallo I; de Vathaire F
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):339-46. PubMed ID: 20646844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term mortality risks among patients with non-metastatic bladder cancer.
    Zhai M; Tang C; Li M; Chen X; Jin Y; Ying X; Tang Z; Wang X; Wu Y; Sun C; Chen K; Guo X
    BMC Cancer; 2020 Nov; 20(1):1148. PubMed ID: 33238972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary and second primary cancer in 649 patients with malignancies of the maxillofacial region.
    Friedrich RE
    Anticancer Res; 2007; 27(4A):1805-18. PubMed ID: 17649777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.
    Tichelli A; Beohou E; Labopin M; Socié G; Rovó A; Badoglio M; van Biezen A; Bader P; Duarte RF; Basak G; Salooja N;
    JAMA Oncol; 2019 Feb; 5(2):229-235. PubMed ID: 30476975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cause of mortality in five-year survivors of childhood cancer in North-West Italy, 1967-1999.
    Dama E; Pastore G; Ferrante D; Magnani C; Maule MM; Merletti F
    Pediatr Blood Cancer; 2008 Apr; 50(4):937. PubMed ID: 18286496
    [No Abstract]   [Full Text] [Related]  

  • 7. Second primary malignancies in patients with hidradenocarcinoma: a US national database study.
    Loya A; Ramachandran V; Nguyen HP
    Clin Exp Dermatol; 2020 Jun; 45(4):453-455. PubMed ID: 31541477
    [No Abstract]   [Full Text] [Related]  

  • 8. Late causes of death in children treated for CNS malignancies.
    Perkins SM; Fei W; Mitra N; Shinohara ET
    J Neurooncol; 2013 Oct; 115(1):79-85. PubMed ID: 23828280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer mortality in long-term survivors of retinoblastoma.
    Marees T; van Leeuwen FE; de Boer MR; Imhof SM; Ringens PJ; Moll AC
    Eur J Cancer; 2009 Dec; 45(18):3245-53. PubMed ID: 19493675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of second primary malignancies in patients with mycosis fungoides: A single-center cohort study.
    Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Duncan LM; Pongas G; Lazaryan A
    J Am Acad Dermatol; 2020 Mar; 82(3):736-738. PubMed ID: 31238085
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of third malignancies and death after a second malignancy in retinoblastoma survivors.
    Marees T; van Leeuwen FE; Schaapveld M; Imhof SM; de Boer MR; Kors WA; Ringens PJ; Moll AC
    Eur J Cancer; 2010 Jul; 46(11):2052-8. PubMed ID: 20400293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term causes of death among pediatric patients with cancer.
    Horn SR; Stoltzfus KC; Mackley HB; Lehrer EJ; Zhou S; Dandekar SC; Fox EJ; Rizk EB; Trifiletti DM; Rao PM; Zaorsky NG
    Cancer; 2020 Jul; 126(13):3102-3113. PubMed ID: 32298481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous and metachronous head and neck carcinomas.
    Schwartz LH; Ozsahin M; Zhang GN; Touboul E; De Vataire F; Andolenko P; Lacau-Saint-Guily J; Laugier A; Schlienger M
    Cancer; 1994 Oct; 74(7):1933-8. PubMed ID: 8082099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of additional malignancies in patients diagnosed with gastrointestinal stromal tumors.
    Smith MJ; Smith HG; Mahar AL; Law C; Ko YJ
    Int J Cancer; 2016 Oct; 139(8):1744-51. PubMed ID: 27299364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second primary neoplasms in thyroid cancer patients.
    Ishikawa K; Noguchi S; Tanaka K; Fukuda A; Hirohata T
    Jpn J Cancer Res; 1996 Mar; 87(3):232-9. PubMed ID: 8613424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona.
    Ameijide A; Clèries R; Carulla M; Buxó M; Marcos-Gragera R; Martínez JM; Vilardell ML; Vilardell M; Espinàs JA; Borràs JM; Izquierdo Á; Galceran J
    Clin Transl Oncol; 2019 Aug; 21(8):1014-1025. PubMed ID: 30607790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment.
    Fallahi B; Adabi K; Majidi M; Fard-Esfahani A; Heshmat R; Larijani B; Haghpanah V
    Clin Nucl Med; 2011 Apr; 36(4):277-82. PubMed ID: 21368600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
    Tadmor T; Liphshitz I; Silverman B; Polliack A
    Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of second primary malignancies after nasopharyngeal carcinoma: a population-based cohort study in Taiwan.
    Lin C; Lin SW; Weng SF; Lin YS
    Head Neck; 2014 Feb; 36(2):209-14. PubMed ID: 23729214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second malignancies in patients with Ewing Sarcoma Family of Tumors: A population-based study.
    Sultan I; Rihani R; Hazin R; Rodriguez-Galindo C
    Acta Oncol; 2010; 49(2):237-44. PubMed ID: 20100158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.